Navigation Links
Therapure Biopharma Inc. Signs Biomanufacturing Contract with ProChon Biotech Ltd.
Date:6/21/2010

Therapure Biopharma Inc. today announced an agreement under which Therapure will provide manufacturing services for ProChon Biotech, a specialty pharmaceutical company based in Israel with an executive management team based in Woburn, MA. Under the terms of the agreement, Therapure will provide services to support clinical manufacturing for one of ProChon’s products, which may be used for reconstructive surgery. The companies are also negotiating contracts for on-going manufacturing services, subject to the product achieving FDA approval. Financial terms were not disclosed.

Toronto, ON (PRWEB) June 21, 2010 -- Therapure Biopharma Inc. today announced an agreement under which Therapure will provide manufacturing services for ProChon Biotech, a specialty pharmaceutical company based in Israel with an executive management team based in Woburn, MA. Under the terms of the agreement, Therapure will provide services to support clinical manufacturing for one of ProChon’s products, which may be used for articular cartilage regeneration. The companies are also negotiating contracts for on-going manufacturing services, subject to the product achieving FDA approval. Financial terms were not disclosed.

ProChon Biotech Limited (Prochon) is a privately owned biotechnology company focused on providing products for articular cartilage regeneration. Prochon’s expertise in modulating the fibroplast growth factor (FGF) enables it to create more effective solutions for tissue regeneration.

“We are pleased to have been chosen by Prochon as its partner to provide clinical manufacturing services” said Thomas Wellner, President and CEO of Therapure. “Therapure has performed these services for a number of clients and has demonstrated market leading expertise.” continued Mr. Wellner.

“We believe that Therapure has the most relevant expertise for successful implementation of our manufacturing requirements.” said Patrick O’Donell, CEO of Prochon Inc.

About Therapure Biopharma Inc.:
Therapure Biopharma Inc. is an integrated biopharmaceutical company that develops, manufactures, purifies and packages therapeutic proteins. As a contract development and manufacturing organization (CDMO) Therapure Biopharma applies scientific, manufacturing, and downstream purification expertise with an intimate understanding of advanced biology, complex proteins, and regulatory processes to develop effective and innovative solutions to advance products from discovery to market for its clients. Therapure’s Health Canada licensed 130,000 sq. ft. facility, includes manufacturing, research and quality control laboratories and a cGMP warehouse, and is built to U.S. FDA, EMEA, MHRA and Health Canada standards for the aseptic handling and purification of proteins.

For more information, please visit: www.therapurebio.com

Company Contacts:

Thomas Wellner, President and CEO
Therapure Biopharma Inc.
+1 905 286-6204

###

Read the full story at http://www.prweb.com/releases/biopharma/manufacturing/prweb4162674.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Microbix And Therapure Biopharma Form Partnership To Expand Water-Based Supplies To The Pharma Industry
2. YM BioSciences Inc. and Therapure Biopharma Inc. Announce Contract
3. Therapure Biopharma Inc. Announces Manufacturing Agreement with Biomedical Frontiers Incorporated -- Contract will Support Phase II Trials for Thalassemia Treatment
4. Therapure Biopharma Inc. announces collaboration with BioVectra Inc.
5. Therapure Biopharma Inc. announces collaboration with Induce Biologics Inc.
6. Therapure Biopharma Inc. opens for business with first client contracts
7. Chinese Biopharmaceutical Association Holds 15th Annual Conference in Rockville, MD, June 12 - 13
8. IntraLinks Announces Partnership With SAFE-BioPharma; Will Provide Digital Identity Capabilities With its Life Sciences Solutions
9. PDL BioPharma to Announce First Quarter 2010 Financial Results and Hold Conference Call on April 29, 2010
10. PDL BioPharma Announces Fourth Quarter and Full Year 2009 Financial Results and Provides First Quarter 2010 Revenue Guidance
11. ClearTrial Launches New Service to Bring Speed and Accuracy in Clinical Trial Planning Within Reach of Smaller Biopharma Companies
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Therapure Biopharma Inc. Signs Biomanufacturing Contract with ProChon Biotech Ltd.
(Date:6/23/2016)... NEW YORK , June, 23, 2016  The ... students to envision new ways to harness living systems ... of Modern Art (MoMA) in New York ... more than 130 participating students, showcased projects at MoMA,s ... included Paola Antonelli , MoMA,s senior curator of ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory ... technical consulting, provides a free webinar on Performing Quality Investigations: Getting ... at 12pm CT at no charge. , Incomplete investigations are still a major ...
(Date:6/22/2016)... 22, 2016 Research and Markets has announced ... report to their offering. ... from $29.3 billion in 2013. The market is expected to grow ... 2015 to 2020, increasing from $50.6 billion in 2015 to $96.6 ... during the forecast period (2015 to 2020) are discussed. As well, ...
Breaking Biology Technology:
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:4/14/2016)... , April 14, 2016 ... Malware Detection, today announced the appointment of Eyal ... new role. Goldwerger,s leadership appointment comes at ... heels of the deployment of its platform at several ... biometric technology, which discerns unique cognitive and physiological factors, ...
Breaking Biology News(10 mins):